News

All of our latest updates

Press releases

News

May 11, 2026
PhD student Anja Ritter made a pitch presentation of her work on the TME gene engineering vector Ad825 at the annual CIMT meeting 2026.
May 11, 2026
Our research was represented by the PhD students Ahmed Calandigary and Anja Ritter at the annual CIMT meeting 2026 and presented two posters: ”Targeting soft-tissue sarcoma with tumor microenvironment gene engineering drives NK cell antitumoral responses and reduces factors that promote tumor progression” Calandigary et al, and ”Immunostimulatory gene therapy targeting CD40, 4-1BB, and PD-L1 reactivates T cell immunity" Ritter et al.
April 19, 2026
Angelica Loskog, CEO/CSO at Lokon, released our promising data combining LOAd703 with nab-paclitaxel, gemcitabine, and atezolizumab (anti-PD-L1) in pancreatic cancer during an oral presentation at the annual AACR meeting.

Media

Malou efter 10
Bengt fick aggressiv cancer - hade ett år kvar att leva
Barncancerfonden
Immunterapi på 100 sekunder
Malou efter 10
Forskarna om cancervaccinet: ”Behövs pengar”
Uppsala universitet
Immunterapi är ett nytt sätt att bekämpa cancer.
Forskarpodden
Virus som dödar cancer